Ritter Daniher Financial Advisory LLC Vertex Pharmaceuticals Inc Transaction History
Ritter Daniher Financial Advisory LLC
- $511 Million
- Q3 2025
A detailed history of Ritter Daniher Financial Advisory LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ritter Daniher Financial Advisory LLC holds 282 shares of VRTX stock, worth $122,393. This represents 0.02% of its overall portfolio holdings.
Number of Shares
282
Previous 282
-0.0%
Holding current value
$122,393
Previous $125,000
12.0%
% of portfolio
0.02%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding VRTX
# of Institutions
1,786Shares Held
231MCall Options Held
1.83MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA25.9MShares$11.2 Billion1.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.2MShares$10.5 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.25 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.6MShares$7.18 Billion1.27% of portfolio
-
State Street Corp Boston, MA11.6MShares$5.04 Billion0.16% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $111B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...